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Purpose: To evaluate the expression patterns of cytokeratin (K) 12, 13, and 19 in normal epithelium of the human ocular
surface to determine whether K13 could be used as a marker for conjunctival epithelium.
Methods: Total RNA was isolated from the human conjunctiva and central cornea. Those transcripts that had threefolds
or higher expression levels in the conjunctiva than the cornea were identified using microarray technique. Expression
levels of three known signature genes and of two conjunctival genes, K13 and K19 were confirmed by using quantitative
real-time PCR (qRT–PCR). Protein expression of K12, K13, and K19 was confirmed by immunostaining with specific
antibodies on histologic sections of human sclerocornea that contained the conjunctiva, limbus, and cornea and on
impression cytology (IC) specimens of the cornea and conjunctiva from normal donors. Double staining of K13/K12 and
K19/K12 on histologic sections and IC specimens was performed.
Results: There were 337 transcripts that were preferentially expressed in the conjunctiva. K13 and K19 were among the
top twenty transcripts in the conjunctiva and this preferential expression pattern of K13 and K19 was confirmed by qRT–
PCR. Immunohistochemical studies showed that K13 was expressed at the posterior limbal epithelium and conjunctival
epithelium but was totally absent in the cornea. K12 was expressed in the corneal and anterior limbal epithelia except for
the basal layer and was absent from the conjunctiva. In contrast, K19 was detected in the corneal, limbal and conjunctival
epithelia. Immunostaining of the IC specimens showed K12+ epithelial cells in the corneal region, K13+ cells in the
conjunctival area, and K19+ cells in the corneal and conjunctival specimens. Expression of K13 and K12 on the ocular
surface was mutually exclusive on both the histologic and IC samples using double immunostaining.
Conclusions: K13 is more specific to the conjunctival epithelial cells than K19 and potentially could be used as a marker
to identify conjunctival epithelial cells in limbal stem cell deficiency.
The  ocular  surface  is  lined  by  the  corneal  and
conjunctival epithelia. Despite having different phenotypes
and histogeneses, both epithelia form a continuous layer and
function as barriers to protect the ocular surface from injury,
infection, and desiccation. The human corneal epithelial stem
cells (limbal stem cells [LSCs]) are presumed to locate in the
limbus, ie, the transitional zone between the cornea and the
conjunctiva, and they maintain the homeostasis of corneal
epithelial cells [1,2]. When LSCs are damaged or deficient,
the conjunctival epithelium invades the corneal surface, and
this invasion leads to corneal opacity and neovascularization
[3]. This conjunctivalization process on the corneal surface
severely impairs vision and causes blindness at the end stage
[4].
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Diagnosis of LSC deficiency (LSCD) is made by clinical
examination and confirmed by impression cytology (IC) [5].
The  presence  of  goblet  cells  on  the  cornea  indicates  the
presence of conjunctival epithelium. However, in many ocular
disorders in which LSCD is observed, goblet cell deficiency
also coexists, and this coexistence leads to a false-negative
result. Egbert et al. [6] found that it is difficult to distinguish
conjunctival epithelia from corneal epithelia by conventional
cytology techniques.
The identification of a marker that is expressed in the
conjunctival epithelium but not in the corneal epithelium has
been a growing need. Good candidates are cytokeratins, which
comprise  a  family  of  intermediate  filament  cytoskeletal
proteins in epithelial cells and are divided into the type I
(acidic)  and  type  II  (basic  to  neutral)  subfamilies.
Cytokeratins form filaments responsible for the integrity of
the epithelial cell structure, and because of their different
patterns  of  expression,  these  proteins  could  be  used  as
differentiation markers [7]. The corneal epithelium, but not
the conjunctival epithelium, expresses cytokeratin (K) 12 [8].
Although K19 was proposed initially by Donisi et al. [9] as a
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1652specific marker of conjunctival epithelial cells and used by
others to diagnose LSCD, other groups found that K19 is not
specific to conjunctival epithelial cells because it is expressed
in corneal epithelial cells as well [10-12]. Barbaro et al. [13]
recently  compared  K12  and  K19  expression  in  both
sclerocorneal  tissues  and  IC  specimens  and  their  results
confirmed the previous finding that K19 is not specific to
conjunctival epithelial cells. A more specific marker of limbal
and conjunctival epithelia would be necessary to detect non-
corneal epithelial cells on the corneal surface.
To search for conjunctival specific marker(s), we first
performed preferential gene profiling in the conjunctiva in
direct  comparison  to  that  in  the  cornea  using  microarray
technique. K13 and K19 transcripts were among the genes
preferentially expressed in the human conjunctiva and their
expression  levels  were  confirmed  using  qRT–PCR.  The
detailed expression patterns of K13, K19, and K12 on the
human  ocular  surface  were  then  compared  by
immunohistochemistry  and  confirmed  on  impression
cytology specimens. K13 was expressed only in the posterior
limbal and conjunctival epithelia and completely absent on
the cornea.
METHODS
Human sclerocorneal tissue: Human sclerocorneal tissue of
nine healthy donors (age range, 2 to 62 years) was obtained
from the Lions Eye Institute for Transplant and Research
(Tampa, FL), the Tissue Bank International (Baltimore, MD),
and  the  San  Diego  Eye  Bank  (San  Diego,  CA).  The
experimental protocol was evaluated and approved by the
Institutional Review Boards of the University of California,
Los  Angeles.  Six  donor  tissues  were  used  in  the
immunohistochemical study. The death to preservation time
was less than 8 h, and the time to tissue processing was less
than 4 days. For RNA isolation, the death to preservation time
was less than 6 h and the tissues were either snap frozen on
dry ice or stored in RNAlater (Ambion Inc., Austin, TX).
Three donors were used in the microarray experiment.
RNA isolation and microarray analysis: The conjunctival and
corneal epithelia along with their immediate adjacent stroma
were dissected from human sclerocorneal tissues. RNA was
isolated as described previously [14]. Briefly, tissues were
homogenized in RLT lysis buffer (Qiagen, Valencia, CA) and
total RNA from tissues was extracted with the Qiagen RNeasy
Mini Kit (Qiagen). The quantity and quality of total RNA were
assessed by a NanoDrop 1000 spectrophotometer (NanoDrop,
Wilmington,  DE)  and  a  2100  Bioanalyzer  (Agilent
Technologies, Santa Clara, CA). Only those samples that had
an RNA integrity number >9 and exhibited minimal RNA
degradation  were  used  for  subsequent  experiments.
Microarray analysis was performed as previously described
[14]. Briefly, one transcription amplification was performed.
Synthesis  for  all  samples  was  successful  and  provided  a
sufficient yield of cRNA. Affymetrix U133 plus 2.0 human
expression arrays (Affymetrix, Santa Clara, CA) was used in
accordance  with  the  standard  Affymetrix  protocol  for
eukaryotic expression arrays. All microarrays were scanned
by using an Affymetrix 3000 one-color microarray scanner.
Raw images were examined for surface defects and for proper
grid  placement.  Background  intensity,  housekeeping  gene
expression, and a 3′-to-5′ ratio of probe sets for genes of
varying lengths were also used to assess the quality. Probe
intensity values were generated by using the Affymetrix Gene
Chip Operating System. The gene whose expression in the
conjunctiva  was  at  least  threefold  higher  than  that  in  the
cornea  and  whose  level  was  ≥145  (1%  of  the  highest
expression level in the conjunctiva) was considered to be
differentially expressed. We have deposited the raw data at
Gene Expression Omnibus (GEO) under accession number
GSE29402  and  we  can  confirm  all  details  are  Minimum
Information  About  a  Microarray  Experiment  (MIAME)
compliant.
Quantitative RT–PCR: Total RNA was reverse-transcribed by
using  Superscript  II  RNase  H2  reverse  transcriptase  (RT;
Invitrogen, Carlsbad, CA) according to the manufacturer's
recommendations. The relative abundance of transcripts was
detected through qRT–PCR by using a Brilliant SYBR Green
qRT–PCR  Master  Mix  (Stratagene,  La  Jolla,  CA).  The
protocol used an Eppendorf realplex2 real-time PCR system
(Hamburg, Germany). The primers used for qRT–PCR are
listed in Table 1. Cycling conditions were as follows: an initial
denaturing step of 10 min at 95 °C and subsequent 40 cycles
of amplification in which each cycle consisted of 45 s at 95 °C,
30 s at 55 °C, and 15 s at 72 °C. To generate a dissociation
curve  after  the  amplification  cycles,  each  sample  was
incubated at 95 °C for 15 s and then subjected to a melting
curve program (60–95 °C). The fluorescence intensity of each
sample was acquired during the execution of the melting curve
program  and  normalized  in  relation  to  that  of  the
housekeeping  gene,  glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The average value of triplicates
from each transcript was used for comparison.
Immunohistochemistry: Human sclerocorneal tissues were cut
into  four  quadrants  and  embedded  in  Optimal  Cutting
Temperature Compound (OCT; Tissue-Tek, Torrance, CA)
on dry ice. Tissues were cut into 6–8 μm sections with a
cryostat and stored at −80 °C. The primary and secondary
antibodies used are listed in Table 2. Frozen section slides
were warmed in a desiccator at room temperature, fixed with
4% paraformaldehyde for 15 min, washed with phosphate-
buffered  saline  (PBS)  three  times,  and  blocked  with  5%
normal  donkey  serum  (Jackson  ImmunoResearch
Laboratories, West Grove, PA) in PBS for 30 min. The slides
were  washed  with  1%  BSA  (BSA)/PBS  three  times  and
incubated with the primary antibodies for 60 min at room
temperature. The slides were washed with 1% BSA/PBS three
times  and  subsequently  incubated  with  the  appropriate
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1653secondary antibody. Afterward, the slides were washed with
1% BSA/PBS three times, and the nuclei were labeled with
Hoechst  33342  (0.5  μg/ml)  for  15  min.  The  slides  were
washed  with  PBS  five  times  and  mounted.  For  double
staining, the slides were incubated with the primary antibody
for 1 h at room temperature, washed with 1% BSA/PBS three
times, and incubated with the appropriate secondary antibody.
The  slides  were  then  incubated  with  the  second  primary
antibody for 1 h at room temperature, washed with 1% BSA/
PBS three times, incubated with the appropriate secondary
antibody for 1 h at room temperature, and washed with 1%
BSA/PBS  three  times.  Nuclei  were  labeled  with  Hoechst
33342 as above. The slides were washed with PBS five times
and mounted. Pictures were taken under a 25× objective lens
by  using  a  Zeiss  fluorescent  microscope  (Oberkochen,
Germany).
Impression Cytology: A sterile, round, single-packed Biopore
0.45-µm  membrane  (Millipore  Corp.,  Bedford,  MA)  was
placed  on  the  cornea  of  the  sclerocorneal  tissues.  Gentle
pressure was applied for a few seconds. The membrane was
then peeled off. To obtain conjunctival epithelial cells, the
membrane was applied to the conjunctiva only in the same
manner. The membranes that contained epithelial cells were
then fixed with 4% paraformaldehyde for 15 min, washed with
PBS three times, and blocked with 5% normal donkey serum
(Jackson ImmunoResearch Laboratories) in PBS for 30 min.
The membranes were immunostained with anti-K12, anti-
K13, and anti-K19 antibodies as described above.
Data analysis: All Affymetrix data were normalized by using
the justRMA algorithm of R software from the Bioconductor
group [15], which implements the RMA (robust multiarray
average) normalization method [16]. In this normalization
step, each array was individually normalized by combining it
with a pool of 50 fixed reference arrays in the Microarray Core
Facility at the University of California, Los Angeles. Genes
whose expression values were at least threefold greater than
those in the other tissue type were selected and considered to
be  differentially  expressed.  DAVID  (the  database  for
annotation, visualization and integrated discovery) was used
for functional analysis [17]. Lists of differentially expressed
genes  were  checked  by  DAVID  to  find  the  most  over-
represented  gene  groups.  The  data  was  obtained  from  3
different donors.
Statistical  analysis:  To  eliminate  the  variation  between
experiments in the qRT–PCR, the absolute expression value
(highest for either the conjunctiva or cornea) was set at 1 and
the ratios of absolute values were calculated between tissues
and averaged. A Wilcoxon Signed-rank test was performed
on the ratio values and a Student’s t test on the quantitation of
cell populations. A p value <0.05 was considered statistically
significant.
TABLE 1. QRT–PCR PRIMERS.
Gene Direction Primer sequence
K12 Forward CCAGGTGAGGTCAGCGTAGAA
  Reverse CCTCCAGGTTGCTGATGAGC
K13 Forward CTGAACAAGGAGGTGTCTACCA
  Reverse ATAGCGGCACTCCGTCTCT
K15 Forward ACCACCACATTTCTGCAAACT
  Reverse AGCTGAGATACTTCGGCTTCC
K19 Forward TGAGTGACATGCGAAGCCAAT
  Reverse ACCTCCCGGTTCAATTCTTCA
Mucin 5AC Forward CAGCCACGTCCCCTTCAATA
  Reverse ACCGCATTTGGGCATCC
GAPDH Forward GGCTGAGAACGGGAAGCTTGTCAT
  Reverse CAGCCTTCTCCATGGTGGTGAAGA
Abbreviations: Cytokeratin, K; Glyceraldehyde 3-phosphate dehydrogenase, GAPDH.
TABLE 2. PRIMARY AND SECONDARY ANTIBODIES.
Protein Company Host Species
reactivity
Clone/ catalog #
Cytokeratin 12 Santa Cruz Biotechnology, Santa Cruz, CA goat human sc-17101
Cytokeratin 13 Santa Cruz Biotechnology, Santa Cruz, CA mouse Human c-101460
Cytokeratin 19 Dako North America Inc., Carpinteria, CA mouse human RCK108
Cytokeratin 19 Leica Microsystems INC, Bannockburn, Il mouse human b170
Alexa Fluor 488 IgG Invitrogen, Carlsbad, CA donkey goat A11055
Alexa Fluor 546 IgG Invitrogen, Carlsbad, CA donkey mouse A10036
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1655RESULTS
The RNA quality assessed by using the nano chip revealed a
flat baseline with no significant tailing of the rRNA bands
(data not shown) and the S18-to-S23 ratios were between 1.6
and 2.1. The RNA isolated from all tissues appeared to have
little degradation.
There were 337 transcripts predominantly overexpressed
in  the  conjunctiva.  Of  the  337  preferentially  expressed
transcripts  in  the  conjunctiva,  331  encoded  proteins  with
known  functions.  The  top  20  transcripts  that  were
preferentially overexpressed in the conjunctiva are listed in
Table 3. Interestingly, both K19 and K13 were among the
preferential intermediate filaments in the conjunctiva.
To  validate  our  microarray  data,  we  analyzed  the
expression pattern of several well known signature genes in
the cornea and conjunctiva from the global mean intensity
values. One of the cornea epithelium markers, keratin 12 [2]
was highly expressed in the cornea. Keratin 15, which had
been shown to be exclusively expressed at the basal epithelial
layer  of  the  limbus  and  conjunctiva  [10],  had  a  higher
transcription level in the conjunctiva than cornea (Figure 1A).
Mucin  5AC,  a  conjunctiva  marker  [18],  was  also
preferentially  expressed  in  the  conjunctiva  but  not  in  the
cornea (Figure 1A). The expression levels of all of these
signature genes of each tissue type were highly correlated with
their expected expression patterns. In addition to the expected
marker expression, both K13 and K19 expression were also
significantly upregulated in the conjunctiva in comparison to
the cornea.
To  further  verify  the  microarray  method,  the  five
transcripts with differential expression patterns seen in our
microarray analysis were independently quantified by qRT–
PCR. The expression levels of all five transcripts measured
by qRT-PCR correlated well with those obtained using the
Figure 1. Expression levels of signature
genes and of K13 and K19 in the cornea
and conjunctiva. Expression levels were
obtained by microarray method (A) and
detected  by  qRT–PCR  (B).  K12
expression was restricted to the cornea
as expected, whereas K15 and Mucin
5AC, both conjunctival markers, were
expressed  almost  exclusively  in  the
conjunctiva.  Both  K13  and  K19
transcripts  were  also  preferentially
expressed  in  the  conjunctiva.
Abbreviations: K, cytokeratin.
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1656microarray  technique  (Figure  1B).  K13  and  K19  were
included  in  this  analysis  to  confirm  their  expression
specificity.  The  levels  of  K13  and  K19  transcripts  were
significantly higher in the conjunctiva than in the cornea (both
p<0.05). K13 and K19 mRNA levels were barely detected in
the cornea (Figure 1B). This observation suggested that K13
could be a candidate conjunctival epithelial marker.
Immunohistochemistry  was  then  used  to  examine  the
presence of K13 and K19 in normal human ocular tissues. A
montage  of  images  consisting  of  the  conjunctiva,  limbus,
peripheral cornea and central cornea was constructed to show
the detailed expression pattern. As shown in Figure 2A, K13
protein was expressed in the suprabasal limbal epithelium and
in all layers of the conjunctival epithelium but was absent in
all layers of the corneal epithelium, including the central and
peripheral areas. As expected, K12 protein expression was
detected  in  all  layers  of  the  corneal  epithelium  and  the
suprabasal layers of the limbus, but was not observed in the
conjunctival epithelium (Figure 2A). K19 was observed in all
layers of the epithelium in the limbus, and the expression
extended to the mid-peripheral cornea, although the intensity
of the fluorescence toward the center of the cornea decreased
Figure 2. Immunohistochemical analysis of expression patterns of K12, K13, and K19 in normal human histologic sections. Montage images
of serial sections of the central cornea to the conjunctiva (A-C): Double staining of K12 (green) and K13 (red) showed the presence of K13
in the epithelia of the posterior limbus and conjunctiva (A). K19 expression was detected in the peripheral cornea, limbus, and conjunctiva
(B). Double staining of K12 (green) and K19 (red) showed the overlapping expression of both cytokeratins (C). D: Expression of K12 (arrows)
and K13 (arrowheads) were mutually exclusive. E: Details of the overlapping expression of K12 and K19. Arrowhead: cells that expressed
both K12 and K19. Arrow: K12-expressing cell. Abbreviations: Conj., conjunctiva. Magnification bar in A, B, C represents 200 μm.
Magnification bar in D and E represents 50 μm.
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1657(Figure 2B). Only occasionally, the central corneal epithelial
cells expressed K19.
To further evaluate the specificity of the expression of
K13 and K19, double immunostaining of the sclerocorneal
tissue  sections  was  performed.  There  was  a  rather  abrupt
transition between the K12-expressing and K13-expressing
epithelial  cells  in  the  limbus  (Figure  2  A,D).  The  limbal
epithelial  cells  expressed  either  K12  or  K13.  Few  cells
expressed  both  K12  and  K13;  this  finding  suggested  that
expression of K12 and K13 is mutually exclusive. In contrast,
epithelial cells that expressed both K12 and K19 were located
throughout  the  limbus  and  the  peripheral  cornea  (Figure
2B,C,E). Quantitation of each population was performed in
the central and the peripheral cornea (Figure 3). In the central
cornea, nearly all epithelial cells were K12+ and 22.6% of
them  also  weakly  expressed  K19  (Figure  3B).  In  the
peripheral cornea, 97.8% of cells were K12+ and 62.7% of
them also were K19+ (Figure 3B). On average, 97.8% of
epithelial  cells  expressed  K12  and  42.9%  of  them  also
expressed K19 in the cornea (Figure 3B). In contrast, none of
the K12+ cells expressed K13 in the central cornea and there
was no K13 expression in the peripheral cornea (Figure 3A).
The statistical differences between the K12+ cells compared
to either the K13+ or K19+ cells were significant for both the
peripheral and central cornea.
The specificity of K12, K13, and K19 expression was
confirmed  on  IC  specimens  of  healthy  donors.  K12  was
detected only in IC specimens from the cornea (Figure 4A),
but not in the conjunctiva (Figure 4B). K13 was present in IC
specimens  from  the  conjunctiva  (Figure  4D)  but  was
completely absent in corneal IC specimens (Figure 4C). In
contrast, K19 was seen in the conjunctival and corneal IC
specimens  (Figure  4E,F).  Double  staining  confirmed  the
K12+/K19+ cells in the cornea (Figure 4H).
DISCUSSION
The identification of K13 and K19 in conjunctiva from the
microarray  analysis  and  subsequent  confirmation  through
qRT–PCR  and  immunostaining  strongly  validates  the
comparative gene expression analysis from the microarray
data. A similar gene expression profile study by Turner et al.
[19] using human genome U133A microarrays, containing
22,283  probe  sets,  compared  RNA  samples  isolated  from
conjunctival  and  cornea  epithelial  sheets.  Interestingly,
almost  all  of  our  preferentially  expressed  genes  in  the
conjunctiva, including K13 and K19, were present in their
conjunctiva  exclusive  or  preferential  transcript  sets,  thus
reaffirming the validity of our microarray results despite the
slight difference in the ocular tissues used.
This study compares the expression specificity of K13
and K19 at both the mRNA and protein levels on the human
Figure 3. Specificity of K12, K13, and
K19  expression  in  human  cornea.  A:
Percentage  of  K12+,  K13+  and  K12+/
K13+  cells  in  the  central  (left)  and
peripheral cornea (middle). The average
percentages of the three cell populations
are obtained (right). B: Percentage of
K12+, K19+ and K12+/K19+ cells in the
central  (left)  and  peripheral  cornea
(middle).  The  average  percentages  of
the three cell populations are obtained
(right). The asterisk indicates a p<0.05
between K12+ and K19+ or K13+ cells,
the double asterisk indicates a p<0.05
between K12+ and K12+/19+ or K12+/
K13+ cells.
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1658Figure 4. Patterns of K 12, 13, and 19 expression in the impression cytology (IC) specimens taken from normal sclerocorneal tissues. A, C,
E, G, and H were from corneal IC specimens. B, D, and F were conjunctival IC specimens. Expression of K12 was present in the corneal
(A) but not in the conjunctival epithelium (B). K13 expression was not detected in corneal epithelium (C) but was highly expressed in the
conjunctival (D) epithelium. K19 was detected in the both corneal (E) and conjunctival (F) epithelia. Double staining of K12/K13 (G) and
K12/K19 (H) in corneal IC specimens. Arrows: K12+/K19+ cells. Magnification bar represents 5 μm.
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1659ocular surface. Although K19 is expressed at a much lower
level in the central cornea, the finding that K19 was detected
in 62.7% of the corneal epithelial cells in the peripheral cornea
is striking. These observations strongly suggest that K19 is
not specific to the conjunctival epithelium. Using qRT–PCR,
we detected a low level of K19 transcripts in the cornea and
confirmed the accuracy of our immunostaining results. The
qRT–PCR  result  probably  reflects  K19  expression  in  the
peripheral  cornea.  Our  finding  is  consistent  with  those
reported  previously  [10,13,20].  The  discrepancy  in  K19
expression  may  be  due  to  the  immunohistochemistry
technique  employed.  The  length  of  fixation,  the  antibody
used, the location of the observation, the quality of specimen,
and the sensitivity of immunofluorescence detection might
affect  the  outcome  of  the  immunostaining  pattern.  Over
fixation tends to decrease antibody-antigen binding and hence
reduce detection sensitivity. Only fresh tissues with less than
8 h of death to preservation time were used in our experiments.
We also employed two different anti-K19 antibodies, and both
gave the same immunostaining pattern.
K13, a major acidic keratin, is expressed in the suprabasal
layers of non-cornified stratified epithelia and is mucosa-
specific [21]. In addition, K13 is present in the suprabasal
layers of most stratified squamous epithelia, such as mucosal
epithelia and regenerating epidermis [22,23]. Previous studies
by  us  and  others  showed  that  K13  is  expressed  in  the
conjunctival  and  limbal  epithelia  in  histological  sections
[14,20,24]  and  in  cultured  tissue  [25],  but  the  detailed
expression pattern on the central and peripheral cornea, and
the limbus has not been studied. This study shows the detailed
expression  pattern  of  K13  and  K19  in  the  central  and
peripheral  cornea,  and  the  limbus.  The  finding  that  K12
expression and K13 expression are mutually exclusive on the
ocular surface makes K13 a potential marker of epithelial cells
that  are  not  of  corneal  phenotype.  This  is  particularly
important because the clinical signs in the early stage of LSCD
tend to be subtle and not specific. Goblet cells are not always
present and could be missed by the standard IC method. The
detection of non-corneal epithelial cells, particularly in the
peripheral cornea, would be a more sensitive and specific
method  of  diagnosing  early  LSCD.  Furthermore,  the
successful detection of K13 and K12 by immunostaining in
IC specimens would allow for using K13 as a diagnostic
maker of conjunctival epithelium in immunocytology. The
sensitivity of K13 as a marker of non-corneal epithelial cells
will need to be determined on pathologic IC specimens.
In addition to the overexpression of K13 and K19 in the
conjunctiva,  two  members  of  the  S100  calcium  binding
protein family, S100A8 and S100A9, were highly expressed
in the conjunctiva. S100 proteins function as calcium sensors
and upon activation, regulate various cell processes in the
epidermis [26]. It has been shown that S100A8 and S100A9
are normally co-expressed together and in response to wound
healing, these proteins are secreted by human keratinocytes
[27].  Furthermore,  localization  of  both  proteins  has  been
observed in both human conjunctival and pterygial epithelia
[24,28], and S100A8/9 can also bind to keratin intermediate
filaments [29]. Future studies will focus on the specificity of
these partner proteins in the conjunctiva.
Another  candidate  we  examined  was  the
carcinoembryonic antigen-related cell adhesion molecule 6
(CEACAM6). CEACAM6 belongs to the carcinoembryonic
antigen gene family and has been shown to be localized on
epithelia in intestinal cells [30]. Preliminary immunostaining
showed  localization  only  in  the  superficial  layer  of  the
conjunctiva and limbus and expression in the cornea was
absent  (data  not  shown).  Despite  being  specific  for  the
conjunctiva and limbus, the lack of expression in the basal and
suprabasal  layers  of  the  epithelia  makes  this  protein  an
undesirable marker.
Although not listed in Table 3, the mucin family had
several genes upregulated in the conjunctiva based on the
microarray  data,  including  mucin  5AC  and  mucin  1.  A
previous report proposed that mucin 1 (MUC1) could be used
as a new marker of conjunctival epithelial cells [13]. However,
others  have  shown  that  expression  of  MUC1  is  uniform
throughout the entire human ocular surface [18,31]. Further
study is needed to determine the expression specificity of
MUC1 and to resolve this discrepancy before MUC1 could be
accepted as a marker of conjunctival epithelial cells.
In summary, the findings of our study show that K13
expression  is  specific  to  non-corneal  epithelial  cells,
particularly conjunctival epithelial cells on the healthy ocular
surface and K19 is present at substantial levels in the corneal
epithelium. The K13 expression pattern and that of K12 are
mutually exclusive. This unique feature of K13 makes it a
potential  candidate  as  a  diagnostic  marker  to  detect  the
invasion of conjunctival epithelial cells onto the cornea, a
hallmark of LSCD.
ACKNOWLEDGMENTS
The authors thank Conde de Valenciana Foundation, the Pan-
American  Ophthalmological  Foundation,  and  the  Retina
Research Foundation (A.R.M.), the International Council of
Ophthalmology International Fellowship (S.Z.G.), National
Eye  Institute  5T32EY007026–35  (M.N.N.)  for  financial
support, and Dr. Thuy Truong for technical help.
REFERENCES
1. Davanger  M,  Evensen  A.  Role  of  the  pericorneal  papillary
structure  in  renewal  of  corneal  epithelium.  Nature  1971;
229:560-1. [PMID: 4925352]
2. Schermer  A,  Galvin  S,  Sun  TT.  Differentiation-related
expression of a major 64K corneal keratin in vivo and in
culture suggests limbal location of corneal epithelial stem
cells. J Cell Biol 1986; 103:49-62. [PMID: 2424919]
3. Tseng SC. Concept and application of limbal stem cells. Eye
(Lond) 1989; 3:141-57. [PMID: 2695347]
Molecular Vision 2011; 17:1652-1661 <http://www.molvis.org/molvis/v17/a183> © 2011 Molecular Vision
16604. Shapiro MS, Friend J, Thoft RA. Corneal re-epithelialization
from  the  conjunctiva.  Invest  Ophthalmol  Vis  Sci  1981;
21:135-42. [PMID: 7251297]
5. Puangsricharern V, Tseng SC. Cytologic evidence of corneal
diseases with limbal stem cell deficiency. Ophthalmology
1995; 102:1476-85. [PMID: 9097795]
6. Egbert  PR,  Lauber  S,  Maurice  DM.  A  simple  conjunctival
biopsy.  Am  J  Ophthalmol  1977;  84:798-801.  [PMID:
596392]
7. Krenzer KL, Freddo TF. Patterns of cytokeratin expression in
impression  cytology  specimens  from  normal  human
conjunctival  epithelium.  Adv  Exp  Med  Biol  1994;
350:289-92. [PMID: 7518181]
8. Chen  WY,  Mui  MM,  Kao  WW,  Liu  CY,  Tseng  SC.
Conjunctival  epithelial  cells  do  not  transdifferentiate  in
organotypic cultures: expression of K12 keratin is restricted
to corneal epithelium. Curr Eye Res 1994; 13:765-78. [PMID:
7531131]
9. Donisi PM, Rama P, Fasolo A, Ponzin D. Analysis of limbal
stem cell deficiency by corneal impression cytology. Cornea
2003; 22:533-8. [PMID: 12883346]
10. Yoshida S, Shimmura S, Kawakita T, Miyashita H, Den S,
Shimazaki  J,  Tsubota  K.  Cytokeratin  15  can  be  used  to
identify the limbal phenotype in normal and diseased ocular
surfaces.  Invest  Ophthalmol  Vis  Sci  2006;  47:4780-6.
[PMID: 17065488]
11. Chen Z, de Paiva CS, Luo L, Kretzer FL, Pflugfelder SC, Li
DQ.  Characterization  of  putative  stem  cell  phenotype  in
human limbal epithelia. Stem Cells 2004; 22:355-66. [PMID:
15153612]
12. Kasper M, Moll R, Stosiek P, Karsten U. Patterns of cytokeratin
and vimentin expression in the human eye. Histochemistry
1988; 89:369-77. [PMID: 2457569]
13. Barbaro V, Ferrari S, Fasolo A, Pedrotti E, Marchini G, Sbabo
A, Nettis N, Ponzin D, Di Iorio E. Evaluation of ocular surface
disorders: a new diagnostic tool based on impression cytology
and confocal laser scanning microscopy. Br J Ophthalmol
2010; 94:926-32. [PMID: 19740872]
14. Ding Z, Dong J, Liu J, Deng SX. Preferential gene expression
in  the  limbus  of  the  vervet  monkey.  Mol  Vis  2008;
14:2031-41. [PMID: 18989386]
15. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M,
Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K,
Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C,
Maechler M, Rossini A. J, Sawitzki G, Smith C, Smyth G,
Tierney L, Yang J, Y, Zhang J. Bioconductor: open software
development for computational biology and bioinformatics.
Genome Biol 2004; 5:R80. [PMID: 15461798]
16. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis
KJ,  Scherf  U,  Speed  TP.  Exploration,  normalization,  and
summaries of high density oligonucleotide array probe level
data. Biostatistics 2003; 4:249-64. [PMID: 12925520]
17. Huang  DW,  Sherman  BT,  Lempicki  RA.  Systematic  and
integrative  analysis  of  large  gene  lists  using  DAVID
bioinformatics resources. Nat Protoc 2009; 4:44-57. [PMID:
19131956]
18. Inatomi T, Spurr-Michaud S, Tisdale AS, Zhan Q, Feldman ST,
Gipson IK. Expression of secretory mucin genes by human
conjunctival  epithelia.  Invest  Ophthalmol  Vis  Sci  1996;
37:1684-92. [PMID: 8675412]
19. Turner HC, Budak MT, Akinci MA, Wolosin JM. Comparative
analysis of human conjunctival and corneal epithelial gene
expression  with  oligonucleotide  microarrays.  Invest
Ophthalmol Vis Sci 2007; 48:2050-61. [PMID: 17460260]
20. Elder MJ, Hiscott P, Dart JK. Intermediate filament expression
by  normal  and  diseased  human  corneal  epithelium.  Hum
Pathol 1997; 28:1348-54. [PMID: 9416689]
21. Waseem A, Alam Y, Dogan B, White KN, Leigh IM, Waseem
NH. Isolation, sequence and expression of the gene encoding
human keratin 13. Gene 1998; 215:269-79. [PMID: 9714826]
22. Kallioinen  M,  Koivukangas  V,  Jarvinen  M,  Oikarinen  A.
Expression of cytokeratins in regenerating human epidermis.
Br J Dermatol 1995; 133:830-5. [PMID: 8547031]
23. Dota  A,  Nishida  K,  Adachi  W,  Nakamura  T,  Koizumi  N,
Kawamoto S, Okubo K, Kinoshita S. An expression profile
of active genes in human conjunctival epithelium. Exp Eye
Res 2001; 72:235-41. [PMID: 11180972]
24. Jaworski CJ, Aryankalayil-John M, Campos MM, Fariss RN,
Rowsey J, Agarwalla N, Reid T. W, Dushku N, Cox C, A,
Carper  D,  Wistow  G.  Expression  analysis  of  human
pterygium shows a predominance of conjunctival and limbal
markers and genes associated with cell migration. Mol Vis
2009; 15:2421-34. [PMID: 19956562]
25. Rosellini A, Papini S, Giannarini C, Nardi M, Revoltella RP.
Human  conjunctival  epithelial  precursor  cells  and  their
progeny in 3D organotypic culture. Int J Dev Biol 2007;
51:739-43. [PMID: 17939121]
26. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K.
S100  proteins  in  the  epidermis.  J  Invest  Dermatol  2004;
123:23-33. [PMID: 15191538]
27. Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T,
Kaesler S, Bugnon P, Reitmaier B, Durka S, Graf A, Wockner
M, Rieger N, Konstantinow A, Wolf E, Goppelt A, Werner
S.  The  Ca2+-binding  proteins  S100A8  and  S100A9  are
encoded by novel injury-regulated genes. J Biol Chem 2001;
276:35818-25. [PMID: 11463791]
28. Riau AK, Wong TT, Beuerman RW, Tong L. Calcium-binding
S100  protein  expression  in  pterygium.  Mol  Vis  2009;
15:335-42. [PMID: 19223989]
29. Goebeler M, Roth J, van den Bos C, Ader G, Sorg C. Increase
of calcium levels in epithelial cells induces translocation of
calcium-binding proteins migration inhibitory factor-related
protein  8  (MRP8)  and  MRP14  to  keratin  intermediate
filaments. Biochem J 1995; 309:419-24. [PMID: 7542868]
30. Benchimol  S,  Fuks  A,  Jothy  S,  Beauchemin  N,  Shirota  K,
Stanners  CP.  Carcinoembryonic  antigen,  a  human  tumor
marker, functions as an intercellular adhesion molecule. Cell
1989; 57:327-34. [PMID: 2702691]
31. Gipson IK, Spurr-Michaud S, Argueso P, Tisdale A, Ng TF,
Russo CL. Mucin gene expression in immortalized human
corneal-limbal and conjunctival epithelial cell lines. Invest
Ophthalmol Vis Sci 2003; 44:2496-506. [PMID: 12766048]
Molecular Vision 2011; 17:1652-1661 <http://www.molvis.org/molvis/v17/a183> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 22 June 2011. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1661